319 related articles for article (PubMed ID: 1518046)
1. Refined 2.3 A X-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors NAPAP, 4-TAPAP and MQPA. A starting point for improving antithrombotics.
Brandstetter H; Turk D; Hoeffken HW; Grosse D; Stürzebecher J; Martin PD; Edwards BF; Bode W
J Mol Biol; 1992 Aug; 226(4):1085-99. PubMed ID: 1518046
[TBL] [Abstract][Full Text] [Related]
2. Geometry of binding of the benzamidine- and arginine-based inhibitors N alpha-(2-naphthyl-sulphonyl-glycyl)-DL-p-amidinophenylalanyl-pipe ridine (NAPAP) and (2R,4R)-4-methyl-1-[N alpha-(3-methyl-1,2,3,4-tetrahydro-8- quinolinesulphonyl)-L-arginyl]-2-piperidine carboxylic acid (MQPA) to human alpha-thrombin. X-ray crystallographic determination of the NAPAP-trypsin complex and modeling of NAPAP-thrombin and MQPA-thrombin.
Bode W; Turk D; Stürzebecher J
Eur J Biochem; 1990 Oct; 193(1):175-82. PubMed ID: 2226434
[TBL] [Abstract][Full Text] [Related]
3. Geometry of binding of the N alpha-tosylated piperidides of m-amidino-, p-amidino- and p-guanidino phenylalanine to thrombin and trypsin. X-ray crystal structures of their trypsin complexes and modeling of their thrombin complexes.
Turk D; Stürzebecher J; Bode W
FEBS Lett; 1991 Aug; 287(1-2):133-8. PubMed ID: 1879520
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of two new bifunctional nonsubstrate type thrombin inhibitors complexed with human alpha-thrombin.
Féthière J; Tsuda Y; Coulombe R; Konishi Y; Cygler M
Protein Sci; 1996 Jun; 5(6):1174-83. PubMed ID: 8762149
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological activity of novel rigid amidino-phenylalanine derivatives as inhibitors of thrombin.
Mack H; Pfeiffer T; Hornberger W; Böhm HJ; Höffken HW
J Enzyme Inhib; 1995; 9(1):73-86. PubMed ID: 8568568
[TBL] [Abstract][Full Text] [Related]
6. The X-ray crystal structure of thrombin in complex with N alpha-2-naphthylsulfonyl-L-3-amidino-phenylalanyl-4-methylpiperidide: the beneficial effect of filling out an empty cavity.
Bergner A; Bauer M; Brandstetter H; Stürzebecher J; Bode W
J Enzyme Inhib; 1995; 9(1):101-10. PubMed ID: 8568562
[TBL] [Abstract][Full Text] [Related]
7. Crystallographic analysis at 3.0-A resolution of the binding to human thrombin of four active site-directed inhibitors.
Banner DW; Hadváry P
J Biol Chem; 1991 Oct; 266(30):20085-93. PubMed ID: 1939071
[TBL] [Abstract][Full Text] [Related]
8. Inhibitor binding to thrombin: x-ray crystallographic studies.
Banner DW; Hadváry P
Adv Exp Med Biol; 1993; 340():27-33. PubMed ID: 8154341
[No Abstract] [Full Text] [Related]
9. Structure-activity relationships of inhibitors derived from 3-amidinophenylalanine.
Stürzebecher J; Prasa D; Wikström P; Vieweg H
J Enzyme Inhib; 1995; 9(1):87-99. PubMed ID: 8568569
[TBL] [Abstract][Full Text] [Related]
10. On the modeling of snake venom serine proteinase interactions with benzamidine-based thrombin inhibitors.
Henriques ES; Fonseca N; Ramos MJ
Protein Sci; 2004 Sep; 13(9):2355-69. PubMed ID: 15322279
[TBL] [Abstract][Full Text] [Related]
11. X-ray crystal structures of thrombin in complex with D-Phe-Pro-Arg and with small benzamidine- and arginine-based "non-peptidic" inhibitors.
Bode W
Adv Exp Med Biol; 1993; 340():15-26. PubMed ID: 8154332
[No Abstract] [Full Text] [Related]
12. The mechanism of binding of low-molecular-weight active site inhibitors to human alpha-thrombin.
Nilsson T; Sjöling-Ericksson A; Deinum J
J Enzyme Inhib; 1998 Feb; 13(1):11-29. PubMed ID: 9879511
[TBL] [Abstract][Full Text] [Related]
13. Profiling the structural determinants for the selectivity of representative factor-Xa and thrombin inhibitors using combined ligand-based and structure-based approaches.
Bhunia SS; Roy KK; Saxena AK
J Chem Inf Model; 2011 Aug; 51(8):1966-85. PubMed ID: 21761917
[TBL] [Abstract][Full Text] [Related]
14. Design of highly potent noncovalent thrombin inhibitors that utilize a novel lipophilic binding pocket in the thrombin active site.
Tucker TJ; Lumma WC; Mulichak AM; Chen Z; Naylor-Olsen AM; Lewis SD; Lucas R; Freidinger RM; Kuo LC
J Med Chem; 1997 Mar; 40(6):830-2. PubMed ID: 9083470
[No Abstract] [Full Text] [Related]
15. Synthesis and characterisation of novel thrombin inhibitors based on 4-amidinophenylalanine.
Reers M; Koschinsky R; Dickneite G; Hoffmann D; Czech J; Stüber W
J Enzyme Inhib; 1995; 9(1):61-72. PubMed ID: 8568567
[TBL] [Abstract][Full Text] [Related]
16. Structure-based design and synthesis of novel thrombin inhibitors based on phosphinic peptide mimetics.
Li M; Lin Z; Johnson ME
Bioorg Med Chem Lett; 1999 Jul; 9(14):1957-62. PubMed ID: 10450962
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the structures of the cyclotheonamide A complexes of human alpha-thrombin and bovine beta-trypsin.
Ganesh V; Lee AY; Clardy J; Tulinsky A
Protein Sci; 1996 May; 5(5):825-35. PubMed ID: 8732754
[TBL] [Abstract][Full Text] [Related]
18. Comparative molecular modeling analysis of-5-amidinoindole and benzamidine binding to thrombin and trypsin: specific H-bond formation contributes to high 5-amidinoindole potency and selectivity for thrombin and factor Xa.
Zhou Y; Johnson ME
J Mol Recognit; 1999; 12(4):235-41. PubMed ID: 10440994
[TBL] [Abstract][Full Text] [Related]
19. The crystal structures of human alpha-thrombin complexed with active site-directed diamino benzo[b]thiophene derivatives: a binding mode for a structurally novel class of inhibitors.
Chirgadze NY; Sall DJ; Briggs SL; Clawson DK; Zhang M; Smith GF; Schevitz RW
Protein Sci; 2000 Jan; 9(1):29-36. PubMed ID: 10739244
[TBL] [Abstract][Full Text] [Related]
20. Human alpha-thrombin inhibition by the active site titrant N alpha-(N,N-dimethylcarbamoyl)-alpha-azalysine p-nitrophenyl ester: a comparative kinetic and X-ray crystallographic study.
Nardini M; Pesce A; Rizzi M; Casale E; Ferraccioli R; Balliano G; Milla P; Ascenzi P; Bolognesi M
J Mol Biol; 1996 May; 258(5):851-9. PubMed ID: 8637015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
